XTL Biopharmaceuticals Ltd.

Director's Dealing • Aug 22, 2007



_________

C004אקס טי אל ביופרמסוטיקלס בע"מ2PublicX T L BIOPHARMACEUTICALS LTD4313Corporation no: 520039470Stock Exchange/Market: אקס טי אל1996352Hasapir 3 , Nes Ziona 76100 , ,Tel: 08-9304444 , Fax: 08-9304445E.mail address: rcohen@xtlbio.comDate of transmission: 22/08/2007              Time of broadcast: 10:08 09:58:54

Reference: 2007-02-366820

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate report on other matterDon't use this form if there is more adequate one

Company's CEO Ron Bentsur, purchaded yesterday a total of 15,279 American Depositary Receipts (ADRs) at an average price of $1.30 per ADR. This brings his direct holdings up to 20,101 ADRs. Company's Director of Finance Bill Kessler, purchaded yesterday a total of 5,000 ADRs at an average price of $1.29 per ADR. This brings his direct holdings up to 5,000 ADRs. Each ADR equals to 10 ordinary shares of the Company.
Attached file _________

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity: XENOGRAFT TECHNOLOGIES LTD
Date of revision of form structure: 28/06/2007
- - -
Name of the Signatory: : Kantor Ronen , , Position of Signatory in the reporting corporation: Legal Consultant & Corporate Secretary
Abba Hillel Silver Telephone: 03-6133371 , Facsimile: 03-6133372 , E-mail: rkantor@kantor-law.com